https://www.selleckchem.com/pr....oducts/Perifosine.ht
To assess non-invasive imaging for detection and quantification of gland structure, inflammation and function in patients with primary Sjogren's syndrome (pSS) using PET-CT with 11C-Methionine (11C-MET; radiolabelled amino acid), and 18F-fluorodeoxyglucose (18F-FDG; glucose uptake marker), to assess protein synthesis and inflammation, respectively; multiparametric MRI evaluated salivary gland structural and physiological changes. In this imaging/clinical/histology comparative study (GSK study 203818; NCT02899377) patients with pSS an
Curtir
Comentario
Compartilhar
